Palo Alto, CANCT05020535Now EnrollingIRB Ready

Intracerebral Hemorrhage Clinical Trial in Palo Alto, CA

Access cutting-edge intracerebral hemorrhage treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.

Sponsored by Johns Hopkins University

Quick Self-Assessment

See if you qualify for this Palo Alto location

Preparing your pre-screening questions...

Expert Care in Palo Alto

Access intracerebral hemorrhage specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related intracerebral hemorrhage treatment provided free

Apply for This Palo Alto Location

Check if you qualify for this intracerebral hemorrhage clinical trial in Palo Alto, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Palo Alto

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Palo Alto site if eligible
  4. 4Begin participation

About This Intracerebral Hemorrhage Study in Palo Alto

This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).

Sponsor: Johns Hopkins University

Who Can Participate

Inclusion Criteria

Confirmed diagnosis of spontaneous, non-traumatic ICH.
10 mL ≤ ICH ≤ 60 mL (confirmed via diagnostic and stability CT scans utilizing volumetric assessment)
Participants receiving anticoagulants are eligible upon reversal and stability within 24hrs after onset of ICH symptoms
Age ≥ 18 years
Able to receive first dose of test article ≤ 24h after onset of ICH symptoms
NIHSS score ≥ 2 at randomization or Glasgow Coma Scale ≥ 5 at randomization
Controlled blood pressure (systolic BP \< 180 mm Hg) at randomization.
Premorbid magnetic resonance spectroscopy (mRS) of 0-2
Has adequate venous access
No planned surgical intervention except EVD
Written informed consent from the patient or legally authorized representative (LAR)

Exclusion Criteria

Unstable hematoma defined as \> 6 mL increase as compared to previous CT volume taken at least 6 hours apart within 24 hrs after onset of ICH symptoms.
Anticipated neurosurgical evacuation by open surgery

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Palo Alto?

Yes, this clinical trial (NCT05020535) has an active research site in Palo Alto, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Intracerebral Hemorrhage Treatment Options in Palo Alto, CA

If you're searching for intracerebral hemorrhage treatment options in Palo Alto, CA, this clinical trial (NCT05020535) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced intracerebral hemorrhage specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all intracerebral hemorrhage clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Palo Alto, CA

See all rheumatoid arthritis clinical trials recruiting in Palo Alto — not just this study.

Browse Rheumatoid Arthritis Trials in Palo Alto →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Palo Alto?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Palo Alto, CA